
Disease-modifying anti-rheumatic drugs improve autonomic neuropathy in arthritis: DIANA study
Syngle A, Verma I, Krishan P, Garg N, Syngle V.
This website is for the U.S, for the other countries please refer to this link.
Syngle A, Verma I, Krishan P, Garg N, Syngle V.
Freedman BI, Bowden DW, Smith SC, Xu J, Divers J.
Raisanen A, Eklund J, Calvet JH, Tuomilehto J.
Hupin D, Pichot V, Celle S, Maudoux D, Calvet JH, Barthélémy JC, Roche F.
Zeng Q, Dong SY, Wang ML, Wang F, Li JM, Zhao XL.
Promotional Communication. The medical devices SUDOSCAN is cleared by the US Food and Drug Administration (FDA). The test allows screening and monitoring of peripheral autonomic neuropathies. It can be performed in diabetic patients or in patients suffering from neurological diseases involving small fibers damage. As with any diagnostic test, its results must be interpreted in a global context including the clinic and other examinations performed. Please read the user manual instructions carefully. Contact our office for more information. Last update: 2021/01/12